Data released by The World Health Organization (WHO) On July 7, 2017 revealed that cases of gonorrhoea are increasingly more difficult to treat due to widespread resistance to antibiotics that were traditionally used to treat those infections.
Monoclonal antibodies are extensively used in research laboratories, diagnostic products and immunotherapy and have multiple advantages over polyclonal antibodies. They exhibit enhanced specificity to single epitopes, have little or no variability, and are easy to modify and customize as required. Read the article on Bitesize Bio…
- Superantigens Elicit “Cytokine Storm”: Responsible T-Cells Identified
- Antibiotic-resistant gonorrhoea on the rise
- Taking up the Challenges of In Vitro Monoclonal Antibody Production
- Mycobacterium tuberculosis Induction of Heme Oxygenase-1 Expression Is Dependent on Oxidative Stress and Reflects Treatment Outcomes
- How SDS-PAGE works